Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma
Article
Bell, Erica H, Zhang, Peixin, Shaw, Edward G et al. (2020). Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma
. JOURNAL OF CLINICAL ONCOLOGY, 38(29), 10.1200/JCO.19.02983
Bell, Erica H, Zhang, Peixin, Shaw, Edward G et al. (2020). Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma
. JOURNAL OF CLINICAL ONCOLOGY, 38(29), 10.1200/JCO.19.02983